0001209191-21-023372.txt : 20210329 0001209191-21-023372.hdr.sgml : 20210329 20210329061225 ACCESSION NUMBER: 0001209191-21-023372 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210205 FILED AS OF DATE: 20210329 DATE AS OF CHANGE: 20210329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bozigian Haig P. CENTRAL INDEX KEY: 0001423837 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 21779376 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-02-05 2021-02-09 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001423837 Bozigian Haig P. 12780 EL CAMINO REAL SAN DIEGO CA 92130 0 1 0 0 Chief Development Officer Stock Option 117.43 2021-02-08 4 A 0 3504 0.00 A 2031-02-08 Common Stock 3504 3504 D Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 8, 2021 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. This amendment is being filed to correct a change in the number of shares in the option grant reported in Table II on the reporting person's original Form 4 filed February 9, 2021. /s/ Darin Lippoldt, Attorney-in-Fact 2021-03-26